Table 1. Laboratory tests during individual PK profiling for patients with hemophilia A.
On FVIII-SHL | Preinfusion | T = 15–30 minute | T = 4 hours | T = 24 hours | T = 48–72 hours | |
---|---|---|---|---|---|---|
On FVIII-EHL | Preinfusion | T = 15–30 minute | T = 4 hours | T = 24 hours | T = 48 hours | T = 72–96 hours a |
ASAT | X | |||||
ALAT | X | |||||
GGT | X | |||||
LDH | X | |||||
AF | X | |||||
Albumin | X | |||||
Urea | X | |||||
Creatinine | X | |||||
Hemoglobin | X | |||||
Hematocrit | X | |||||
Thrombocytes | X | |||||
Blood group (if unknown) | X | |||||
Factor VIII | X | X | X | X | X | X |
VWF:Ag | X | X | X | X | X | X |
VWF:Act | X | X | X | X | X | X |
VWF:CB | X | X | X | X | X | X |
VWFpp | X | X | X | X | X | X |
Inhibitor FVIII (only ≥ 18 years) | X | |||||
Bethesda FVIII | X | |||||
Buffycoat | X | |||||
APTT | X | X | X | X | X | X |
PT/INR | X | |||||
Factor V | X | |||||
Fibrinogen | X | |||||
Max of 10-mL citrate plasma | X | X | X | X | X | X |
Abbreviations: AF, alkaline phosphatase; ALAT, alanine aminotransaminase; APTT, activated partial thromboplastin time; ASAT, aspartate aminotransferase; EHL, extended half-life; FIX, factor IX; FV, factor V; FVIII, factor VIII; GGT, gamma-glutamyltransferase; INR, international normalized ratio; LDH, lactate dehydrogenase; PFA, platelet function assay; PK, pharmacokinetic; PT, prothrombin time; SHL, standard half-life; T, time point; VWF:Act, von Willebrand's factor activity; VWF:Ag, von Willebrand factor antigen; VWF:CB, von Willebrand factor collagen binding; VWFpp, von Willebrand factor propeptide.
Only in case of an EHL concentrate.